Guo-fu Hu

2.8k citations
18 papers · 2.2k indexed · h-index 18
Topics
Angiogenesis and VEGF in Cancer (7 papers)Prostate Cancer Treatment and Research (5 papers)RNA Research and Splicing (4 papers)
Partner nations
United StatesJapanChina

In The Last Decade

Guo-fu Hu

18 papers receiving 2.2k citations

Peers

Guo-fu Hu
Comparison fields: 5 of 101
  • Molecular Biology 1.6k
  • Cancer Research 692
  • Oncology 456
  • Cell Biology 188
  • Immunology 185
Replace Takanori Tsuji with:
Takanori Tsuji United States
Kosuke Akiyama Japan
Martin Hagedorn France
Arjan J. Groot Netherlands
Jürgen Dittmer Germany
Anna Sebestyén Hungary
Jason Howitt Australia
Matthew Holderfield United States
Sven Christian Germany
Ferenc Boldog United States
Guo-fu Hu relative to Takanori Tsuji United States Takanori Tsuji's profile →
Citations per field
00.5×2.7×
Takanori Tsuji · 1×
Citations per year

Countries citing papers authored by Guo-fu Hu

Since Specialization
Citations

This map shows the geographic impact of Guo-fu Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo-fu Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo-fu Hu more than expected).

Fields of papers citing papers by Guo-fu Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guo-fu Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo-fu Hu. The network helps show where Guo-fu Hu may publish in the future.

Co-authorship network of co-authors of Guo-fu Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Guo-fu Hu. A scholar is included among the top collaborators of Guo-fu Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guo-fu Hu. Guo-fu Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 20
2 250
3 32
4 47
5 48
6 28
7 398
8 35
9 341
10 42
11 121
12 176
13 43
14 131
15 162
16 272
17 20
18 17

About Guo-fu Hu

Guo-fu Hu is a scholar working on Immunology and Allergy, Cancer Research and Molecular Biology, having authored 18 papers that have together received 2.2k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (7 papers), Prostate Cancer Treatment and Research (5 papers) and RNA Research and Splicing (4 papers). The work is most often cited by research in Cancer Research (692 citations), Molecular Biology (1.6k citations) and Oncology (456 citations). Guo-fu Hu has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Takanori Tsuji, Soichiro Ibaragi, Koji Kishimoto, Karen A. Olson, Shumei Liu, Mohamed M. Emara, Nancy Kedersha, Tyler Hickman, Pavel Ivanov and Paul Anderson. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026